Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?

Executive Summary

After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office

You may also be interested in...



FTC Rulemaking Could Be Next (And Last?) Attempt To Curb "Pay-For-Delay"

Potential Federal Trade Commission rule-making looms over the contentious issue of "pay -for-delay" in brand/generic settlements, particularly as the judicial and legislative environments remain uncertain.

FTC Rulemaking Could Be Next (And Last?) Attempt To Curb "Pay-For-Delay"

Potential Federal Trade Commission rule-making looms over the contentious issue of "pay -for-delay" in brand/generic settlements, particularly as the judicial and legislative environments remain uncertain.

Reverse Settlements: FTC Commissioner, Circuit Judge, Former Solicitor General Debate When A Deal Is Acceptable

Key players in the battle over reverse settlements between brand name and generic drug manufacturers offered ways to resolve the issue at a recent in-house counsel forum on pharmaceutical antitrust

Related Content

Topics

UsernamePublicRestriction

Register

MT142313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel